A61K 31/714
Cobalamins
Official title: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
A61K31/714 (Cobalamins) appears on 729 US grants and 1,542 published applications in this corpus.
Search patents in A61K- Granted patents
- 729
- Published applications
- 1,542
- Assignees
- 643
- Inventors
- 2,093
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 1 |
| 2002 | 8 | 16 |
| 2003 | 9 | 26 |
| 2004 | 9 | 28 |
| 2005 | 5 | 47 |
| 2006 | 9 | 48 |
| 2007 | 6 | 43 |
| 2008 | 12 | 49 |
| 2009 | 6 | 36 |
| 2010 | 11 | 41 |
| 2011 | 16 | 49 |
| 2012 | 19 | 33 |
| 2013 | 27 | 47 |
| 2014 | 23 | 60 |
| 2015 | 36 | 93 |
| 2016 | 39 | 97 |
| 2017 | 48 | 68 |
| 2018 | 40 | 77 |
| 2019 | 43 | 85 |
| 2020 | 45 | 73 |
| 2021 | 48 | 98 |
| 2022 | 65 | 118 |
| 2023 | 31 | 88 |
| 2024 | 52 | 78 |
| 2025 | 31 | 62 |
| 2026 | 26 | 81 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Compositions and methods for increasing T cell function15 Sep 2026US 12,734,150 B2Ludwig Institute for Cancer Research
- Powdered food supplement for producing a beverage1 Sep 2026US 12,721,878 B2PM-International AG
- Compositions for promoting longevity and methods of using the same4 Aug 2026US 12,697,348 B2Vital Nutrition and Health Inc
- Caffeine-free ready-to-drink composition for pre-caffeine cognitive priming28 Jul 2026US 12,691,061 B1
- Compositions, Kits, and Methods Comprising Bioidentical D BHB With Optional Vitamin B6 for Neurological Wellness, Mood Stability, and Medication Taper Support8 Oct 2026US 2026/0306430 A1Global Ketone Limited
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Beta-hydroxybutyrate for the dietary management of depression1 Oct 2026US 2026/0294854 A1Laureate Institute For Brain Research
- Ingestible formulations comprising methylliberine and one or more sugars and their use to treat the adverse effects of alcohol consumption1 Oct 2026US 2026/0294917 A1Lucid Psycheceuticals Inc.
- Compositions and compounds including lithium orotate1 Oct 2026US 2026/0294962 A1Atlantis Software Company
Most cited
By later US patents
- Maximizing effectiveness of substances used to improve health and well being104US 5,945,123 AK-V Pharmaceutical Company · 1999
- Soft capsules98US 7,846,475 B2Wakunaga Pharmaceutical Co., Ltd. · 2010
- Chewable dosage forms97US 5,637,313 AWatson Laboratories, Inc. · 1997
- Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty83US 5,326,757 AHealth Maintenance Programs, Inc. · 1994
- Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors79US 6,210,950 B1University of Medicine and Dentistry of New Jersey · 2001